Article info

Download PDFPDF
Original research
GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance

Authors

  1. Correspondence to Dr Eino Solje, Institute of Clinical Medicine, Department of Neurology, University of Eastern Finland, Kuopio FI-70211, Finland; eino.solje{at}uef.fi
View Full Text

Citation

Katisko K, Cajanus A, Huber N, et al
GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance

Publication history

  • Received February 25, 2021
  • Accepted June 12, 2021
  • First published June 29, 2021.
Online issue publication 
November 16, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.